Lyndal K. Hesterberg
2019
In 2019, Lyndal K. Hesterberg earned a total compensation of $1.2M as Chief Scientific Officer at Oncocyte Corp, a 43% increase compared to previous year.
Compensation breakdown
| Bonus | $60,000 |
|---|---|
| Option Awards | $857,112 |
| Salary | $298,448 |
| Other | $1,250 |
| Total | $1,216,810 |
Hesterberg received $857.1K in option awards, accounting for 70% of the total pay in 2019.
Hesterberg also received $60K in bonus, $298.4K in salary and $1.3K in other compensation.
Rankings
In 2019, Lyndal K. Hesterberg's compensation ranked 8,368th out of 13,971 executives tracked by ExecPay. In other words, Hesterberg earned more than 40.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,368 out of 13,971 | 40th |
Division Manufacturing | 3,307 out of 5,695 | 42nd |
Major group Chemicals And Allied Products | 1,252 out of 2,194 | 43rd |
Industry group Drugs | 1,063 out of 1,880 | 44th |
Industry In Vitro and In Vivo Diagnostic Substances | 31 out of 77 | 60th |
Source: SEC filing on May 26, 2020.
Hesterberg's colleagues
We found five more compensation records of executives who worked with Lyndal K. Hesterberg at Oncocyte Corp in 2019.
2019
Ronald Andrews
Oncocyte Corp
Chief Executive Officer
2019
William Annett
Oncocyte Corp
Chief Executive Officer
2019
Mitchell Levine
Oncocyte Corp
Chief Financial Officer
2019
Albert Parker
Oncocyte Corp
Chief Operating Officer
2019
Padma Sundar
Oncocyte Corp